ScholarIQanswers from OpenAlex

Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival

PaperCitations, authors & open-access status

Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival have?

ScholarIQcitation count

Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival has 86 citations in the OpenAlex counts ScholarIQ stores.

When was Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival published?

ScholarIQyear

Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival has 2018 year in the ScholarIQ index.

What is the open-access status of Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival?

ScholarIQoa status

Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival has bronze oa status in the ScholarIQ index.

What is the DOI of Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival?

ScholarIQdoi

The DOI for Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival is on the source record.

What is the PMID of Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival?

ScholarIQpmid

The PMID for Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival is on the source record.

What is the OpenAlex record for Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival?

ScholarIQopenalex

The OpenAlex for Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial